Delivery Order SPE2DR25D3505-SPE2DR26F96F9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $110,199.71 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count units) under a firm fixed price contract. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at...
- The Defense Logistics Agency awarded a delivery order valued at $33,570.41 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count units) on October 20, 2025, with an ultimate completion date of October 21, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Gilenya 0.5 mg capsules (30-count) valued at $11,008.02 under a firm fixed price arrangement. The contract, which is not set-aside, is scheduled for completion by August 29, 2025, with performance based in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $9,505.56 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count package) on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Gilenya is a disease-modifying therapy used in the treatment of multiple sclerosis and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Gilenya 0.5 mg capsules (30-count units) with a ceiling value of $20,252.06. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency Troop Support Medical awarded a $12,350.54 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 capsules of the 0.5 mg dosage of Gilenya, to be delivered to their location in Conshohocken, Pennsylvania between August 11-14, 2023. Amerisourcebergen will fulfill the order for the multiple sclerosis drug from their corporate office division. The delivery order was issued against an existing DLA medical supply vehicle and no subcontractors or...
- The Defense Logistics Agency awarded a delivery order valued at $15,630.00 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (quantity: 30 units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $3,038 firm fixed price delivery order to AmerisourceBergen Drug Corporation for 4561412045 Gilenya 0.5 mg capsules. The order is for 30 capsules to be delivered to a facility in Conshohocken, Pennsylvania by July 6, 2023. AmerisourceBergen will supply the multiple sclerosis medication to the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense, under an indefinite-delivery/indefinite-quantity contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $69,163.45, is for the supply of the prescription medication Gilenya 0.5 mg capsules. The contract is a firm fixed-price delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a $2,989.64 firm fixed price delivery order to Amerisourcebergen Drug Corp for 30 capsules of the 0.5 mg dosage of Gilenya to treat multiple sclerosis. Amerisourcebergen Drug Corp will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 3, 2023 under the terms of the order. The prime contractor, Amerisourcebergen Drug Corp, is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor and services...
- SPE2DR25D3505Indefinite Delivery Contract
- SPE2DR25D3505-SPE2DR26F96F9Delivery Order
The Defense Logistics Agency awarded a $12,409.85 delivery order to AmerisourceBergen Drug Corp for Gilenya 0.5 mg capsules (30-count) under a firm fixed-price contract, with performance at the awardee's Conshohocken, Pennsylvania facility. This non-set-aside award was issued on December 30, 2025, with an ultimate completion date of December 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, was selected through competitive procurement to supply this neurological treatment medication to support federal medical needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive federal contract portfolio demonstrates consistent capability in fulfilling competitive medical procurement requirements across multiple therapeutic domains through delivery orders ranging from minimal to substantial values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 12/29/25 |